載入中
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
NASDAQHealthcareMedical - Devices
最新資料
US$0.77
−US$0.02 · -2.53%
前收盤價
US$0.77
−US$0.02 · -2.53%
盤中時間採用ET。市場資料可能有所延遲。
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
日內區間
目前US$0.77
52週區間
目前US$0.77
盤中時間採用ET。市場資料可能有所延遲。
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
日內區間
目前US$0.77
52週區間
目前US$0.77
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2253.7萬 USD | 3703.71萬 USD | 3145.79萬 USD | 3509.12萬 USD | 2772.24萬 USD |
| 銷貨成本 | 365.33萬 USD | 438.34萬 USD | 422.74萬 USD | 705.43萬 USD | 454.42萬 USD |
| 毛利 | 1888.37萬 USD | 3265.37萬 USD | 2723.05萬 USD | 2803.69萬 USD | 2317.82萬 USD |
| 研究與開發 | 2013.1萬 USD | 617.44萬 USD | 427.49萬 USD | 385.94萬 USD | 104.01萬 USD |
| 銷售、一般及管理費用 | 2438.35萬 USD | 996.43萬 USD | 1109.39萬 USD | 1054.57萬 USD | 1022.09萬 USD |
| 營業費用 | 4442.11萬 USD | 1733.87萬 USD | 1536.88萬 USD | 1302.97萬 USD | 975.77萬 USD |
| 利息收入 | — | 393 USD | — | 8553 USD | 2326 USD |
| 利息支出 | 73.74萬 USD | 57.68萬 USD | 28.43萬 USD | 29.93萬 USD | 15.39萬 USD |
| 折舊和攤銷 | 110.41萬 USD | 150.74萬 USD | 138.08萬 USD | 147萬 USD | 139.97萬 USD |
| 營業利益 | −2553.74萬 USD | 1531.5萬 USD | 1186.17萬 USD | 1363.17萬 USD | 1191.72萬 USD |
| 淨利 | −2727.8萬 USD | 1245.34萬 USD | 1054.6萬 USD | 1256.88萬 USD | 1167.66萬 USD |
公司資料更新於 2026年10月11日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
